Atlas Trials

High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma

Clinical trial NCT06625359 · TERMINATED

Trial details

NCT number
NCT06625359
Sponsor
Seoul National University Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Central Nervous System Lymphoma
Start date
2015-06-01
Primary completion
2024-09-30
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.